#neurorunners

On my way to 🇲🇽!! Will be participating in several events for #ParkinsonsAwarenessMonth and visiting several LARGE-PD GP2 sites in Mexico City and Monterrey! Excited to see Mayela R. Violante 🧠 ingrid estmann 🇲🇽 Dr. Daniel Martinez, PhD Paula Reyes Ana Jimena Hernández-Medrano

Acompáñanos el jueves 11 de abril Academia Nacional de Medicina de México Instituto Nacional de Neurología y Neurocirugía MDS en el #DíaMundialParkinson #ParkinsonsAwarenessMonth información para público en general.

Hoy tuvimos el honor de recibir en el Tecnológico de Monterrey a Ignacio Fernandez “Nacho” Mata, PhD, Agradecemos profundamente a Nacho por su visita y por enriquecer nuestra comunidad académica y científica con su presencia y sabiduría. Su trabajo inspira y motiva. Nacho Mata

#WorldParkinsonsDay Trastornos del movimiento — MX 🧠 MDS Instituto Nacional de Neurología y Neurocirugía Academia Nacional de Medicina de México Hablemos de Parkinson, que te interesa saber?

Estamos en vivo En línea en youtube.com/live/4J2y1xWi2 hablando de la Enfermedad de Parkinson Dr. Daniel Martinez, PhD Academia Nacional de Medicina de México Instituto Nacional de Neurología y Neurocirugía #WorldParkinsonsDay

1/ The Global Burden of Disease study came out with a new report on global burden of neurological disorders - estimates that 11.8 million people have #Parkinson in 2021 (up from ~6.1-6.3 million for ~2016). This growth far exceeds previous estimates.   thelancet.com/action/showPdf…

Thank you MDS PAS for the invitation, it was an excellent session with a lot of learning. MDS AMN Neurología

Open letter to my dear Alzheimer's patients. Alzheimer's Association

Excelente manera de iniciar mis 43 años 21k San Nicolás 1:42”🏅 Animo #doctorrunner 21K San Nicolás 🐯

You are normal but tested positive for amyloid. Will you get dementia? Here is your Essential Consumer Guide.

Scientists should get paid for thinking time nature #PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science

When should you consider active management of tics? Danny Martinez our old ⁦Norman Fixel Institute for Neurological Diseases⁩ nails it on one slide. Treat the person not the paper! Use these common sense points to guide your decisions.

One of my favourite sessions ever @ChristosGanos Dr. Daniel Martinez, PhD MDS

#IAPRD2025 is extending the abstract submission deadline to 20 December 2024 by popular demand! Join us to present your work in New York City next May. iaprd-world-congress.com/iaprd-2025/abs… Parkinsonism & Related Disorders

En el deporte, el público tiene el poder de cambiar la historia. Una ovación hace 2,000 años decidió un combate épico. Hoy, como fanáticos, somos el jugador más influyente. ¡Anima con pasión y haz la diferencia! ¡Vamos Rayados! #ElPoderDelPúblico #VamosRayados #LigaMX

#IAPRD2025 is pleased to co-host this session with the Mount Sinai Health System. Check out the full scientific program and register for the Congress now to get the best rates! iaprd-world-congress.com Parkinsonism & Related Disorders

From Mentee to Mentor. In 2018, the MDS LEAP Program transformed my life as a mentee. Today, I proudly return as a mentor, guiding the next rising star in movement disorders. Want to know how this experience is making a lasting impact? MDS Philippe Salles

The randomized trial results are in for the GLP-1 drug Exenatide for Parkinson's disease. Spoiler: NO symptomatic or disease modifying effect. Tom Tom Foltynie David Standaert MD, PhD and I interviewed in the The New York Times Gina Kolata on the latest paper just published in The Lancet by Tom and